Related Experiment Video
Updated: Aug 16, 2026
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Multimodal treatment of adult intracranial gliomas
1Section of Neurosurgery, Indiana University School of Medicine, Indianapolis.
Abstract:
Recent advances, experimental treatments and future protocols of adult intracranial gliomas are discussed in this article. Adult intracranial gliomas are not benign, and most are incurable with poor prognosis, despite aggressive treatment. Breakthroughs will be found only through well-designed, experimental protocol evaluation on patients with intracranial gliomas.
Insights
Adult intracranial gliomas are aggressive brain tumors with a poor prognosis. Future breakthroughs in treating these incurable tumors depend on rigorous evaluation of experimental treatment protocols in clinical trials.
Area of Science:
- Neuro-oncology
- Clinical Neurology
- Cancer Research
Background:
- Adult intracranial gliomas represent a significant challenge in neuro-oncology.
- Despite aggressive multimodal treatments, outcomes remain poor with limited curative options.
- Understanding the biology and treatment landscape is crucial for improving patient survival.
Purpose of the Study:
- To review recent advances in the treatment of adult intracranial gliomas.
- To discuss current experimental therapies and their potential impact.
- To highlight the importance of future clinical trial protocols.
Main Methods:
- Literature review of recent advancements in adult intracranial glioma treatment.
- Analysis of experimental treatments and ongoing research protocols.
- Discussion of prognostic factors and therapeutic challenges.
Main Results:
- Current treatments for adult intracranial gliomas are largely ineffective for achieving a cure.
- Most patients face a poor prognosis even with aggressive therapeutic approaches.
- Significant progress is hindered by the aggressive nature of these brain tumors.
Conclusions:
- Adult intracranial gliomas are aggressive and often incurable malignancies.
- Advancements necessitate a focus on well-designed experimental treatment protocols.
- Future breakthroughs are contingent upon robust clinical evaluation in patient cohorts.
